Skip to main content
Signal8

Glucotrack, Inc. (GCTK)

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

GlucoTrack, Inc. logo

GlucoTrack, Inc.

OTC:GCTKOTC (suspended from Nasdaq on Oct 30, 2026)Healthcare
-1.79%$0.1870
Mkt Cap$221K
EV-
Float1.09M
O/S1.18M
VOL6K sh
$ Vol$1K
RVOL0.00×
Inst Own3.9%
Net Cash/Sh-
Dilution

Glucotrack, Inc. (GCTK) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 45 SEC filings.

Shelf registration
S-3 filed Jan 13, 2026, effective Jan 27, 2026
Source: 424B3 filed Jan 27, 2026
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
20 warrant series recorded as outstanding
Most recent offering
PIPE, closed Oct 22, 2026
Source: 8-K filed Oct 22, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro